Life sciences news
-
Ziphius Vaccines and Ghent University publish promising data from self-amplifying RNA platform in Molecular Therapy
Friday May 6th 2022
Read more
-
argenx announces positive Phase 3 data from ADVANCE trial of VYVGART® (efgartigimod alfa-fcab) in adults with primary immune thrombocytopenia
Thursday May 5th 2022
Read more
-
The European Spatial Biology Center (ESBC): State-of-the-art spatial biology services enabled at scale in Leuven
Thursday May 5th 2022
Read more
-
New study led by Memorial Sloan Kettering Cancer Center (NY, US) shows Idylla™ GeneFusion Assay enables more rapid screening of targetable fusions compared to routine methods
Wednesday May 4th 2022
Read more
-
reMYND’s novel Alzheimer program reports excellent brain exposure and safety profile in Phase 1; transitioning into Phase 2a
Tuesday May 3rd 2022
Read more
-
Biotalys obtains new fungicide resistance class for its first biofungicide
Tuesday May 3rd 2022
Read more
-
miDiagnostics launches its CE-IVD certified ultra-fast COVID-19 PCR test
Monday May 2nd 2022
Read more
-
Flanders launches new tech ecosystem platform to connect start-ups to investors
Friday April 29th 2022
Read more
-
Become a flanders.bio member
Your news here?
-
Kantify and I-Stem Use Artificial Intelligence to discover a promising therapy against a rare disease
Wednesday April 27th 2022
Read more
-
Univercells announces the acquisition of RLM Consulting
Wednesday April 27th 2022
Read more
-
flanders.bio zet Vlaamse agro-voedingstechnologie op de internationale kaart
Tuesday April 26th 2022
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
